Why does cervical cancer occur in a state-of-the-art screening program? - Wikidata - wikimedia - TriplyDB

Why does cervical cancer occur in a state-of-the-art screening program?

Why does cervical cancer occur in a state-of-the-art screening program?

http://www.wikidata.org/entity/Q40162758

about

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.

P2860

Q42369427-8EBCA93C-313C-4EBC-A444-3C24C0E1A006 Q52680864-90440303-4D0B-4610-94FF-29FE8496E0F9

P2860

Why does cervical cancer occur in a state-of-the-art screening program?

http://www.wikidata.org/entity/Q40162758

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Why does cervical cancer occur in a state-of-the-art screening program?

@en

type

label

Why does cervical cancer occur in a state-of-the-art screening program?

@en

prefLabel

Why does cervical cancer occur in a state-of-the-art screening program?

@en

P1433

Q40162758-383AE03A-4A0E-4628-9087-A097EA25950C

P1476

Q40162758-08132D68-996E-4674-A928-422252376F49

P2093

Q40162758-1A670167-5C39-42C3-8BBD-B1921EAAF008

Q40162758-1B1775AD-7EFB-422E-8114-7436C5B2548C

Q40162758-33334D7B-11D7-403F-BBB6-586B56527250

Q40162758-47C50C9C-BD4F-4964-B083-491EF6F097CD

Q40162758-47D9B63C-BCA0-4CCF-A222-655AEF6DE07D

Q40162758-948818B5-C251-41FA-B64B-0D9188224657

Q40162758-B5F4396D-F490-47EE-A64E-DC06CE7516F2

Q40162758-DDEFBCFA-09E4-47C4-BC68-85BB6CDB8C90

Q40162758-E09BCD05-1989-4F92-BDDD-6B136AD3A7FE

Q40162758-F9DC169E-FD0F-4B7E-999E-5D849BAE8888

P2860

Q40162758-0994F17E-4327-4D05-8C31-89091267E57E

Q40162758-0D6F591B-4CE8-40A0-A3D7-CFBA84C1F217

Q40162758-0DBF0EE4-0085-4F14-8D2F-70BD8D398C38

Q40162758-1639E52D-4ABC-438E-9BDD-AA312848A7B0

Q40162758-1A441C95-5546-45D4-9380-16A5CE29DDC0

Q40162758-1B39AFD0-4AF2-4C72-841D-DBEFDC99B252

Q40162758-1CB927F7-339E-4CE7-ACF4-33ECAE336F6D

Q40162758-2A6A94CE-7D2C-4C41-9CF0-2302C361D764

Q40162758-2C727074-74B9-4CCE-B894-938ACEE83DD9

Q40162758-2D747367-B1D4-4301-8A36-33BA7A425209

P304

Q40162758-FF26B4B2-D9EE-496B-868F-220D8CE89102

P31

Q40162758-F15B33C6-3FC6-47FD-BE6E-1171CEE8CECB

P356

Q40162758-74F2B436-C505-4EEF-9DAB-98289B8ADCD8

P407

Q40162758-58AF8673-98CC-4D7D-8399-9526043CF915

P433

Q40162758-DC98660D-CD1E-4539-A99C-FBD656F40316

P478

Q40162758-8D0FDA0C-3060-4A70-B006-8CDFBC54F1E3

P50

Q40162758-45B78D9D-2F96-4B45-8481-9369F4AE51D8

Q40162758-D1CCBCD0-524A-42BB-A92C-10C86D91F882

P577

Q40162758-A61311F8-D2AD-4B8E-9AE7-CA270BD1363F

P698

Q40162758-C1E84F5C-C9C0-45CB-8525-9D5A51CB6D9C

P932

Q40162758-E84A60A6-C211-4C26-A0EF-7705B21A3329

P356

J.YGYNO.2017.06.003

P1433

Gynecologic Oncology

P1476

Why does cervical cancer occur in a state-of-the-art screening program?

@en

P2093

Barbara Fetterman

http://www.w3.org/2001/XMLSchema#string

Brian Befano

http://www.w3.org/2001/XMLSchema#string

Hormuzd A Katki

http://www.w3.org/2001/XMLSchema#string

John Schussler

http://www.w3.org/2001/XMLSchema#string

Julia C Gage

http://www.w3.org/2001/XMLSchema#string

Li C Cheung

http://www.w3.org/2001/XMLSchema#string

Nancy E Poitras

http://www.w3.org/2001/XMLSchema#string

Philip E Castle

http://www.w3.org/2001/XMLSchema#string

Thomas S Lorey

http://www.w3.org/2001/XMLSchema#string

Walter K Kinney

http://www.w3.org/2001/XMLSchema#string

P2860

Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ

Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.

Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.

Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.

P304

546-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2017.06.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Wentzensen

P577

2017-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28606721

http://www.w3.org/2001/XMLSchema#string

P932

5743197

http://www.w3.org/2001/XMLSchema#string